MARRONE BIO INNOVATIONS INC.
MARRONE BIO INNOVATIONS INC.
Eröffnung: -
Veränderung: -
Volumen: -
Tief: -
Hoch: -
Hoch - Tief: -
Typ: Aktien
Ticker: MBII
ISIN:

MARRONE BIO INVESTOR ALERT - Kuznicki Law PLLC Investigates Proposed Sale of Marrone Bio Innovations, Inc. - MBII

  • 16

Kuznicki Law PLLC is investigating the proposed sale of Marrone Bio Innovations, Inc. (NasdaqCM: MBII) to Bioceres Crop Solutions Corp. (NasdaqGS: BIOX). Under the terms of the proposed transaction, shareholders of Marrone will receive only 0.088 shares of Bioceres for each share of Marrone that they own.

If you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, contact us toll free at 833-938-0905, via email ([email protected]), or visit https://kclasslaw.com/cases/ma/nasdaqcm-mbii/ to learn more.

Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company’s stock. Attorney advertising. Prior results do not guarantee similar outcomes.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220504006199/en/

Business Wire
Business Wire
Als Tochterunternehmen von Berkshire Hathaway ist Business Wire weltweit führend bei der Verbreitung von Pressemitteilungen und Vorschriften der Unternehmen. Kommunikation und Marketing Profis verlassen sich voll auf Business Wire für ihre Mitteilungen, Fotos und Videos für die Weitergeleitung an Nachrichtenagenturen, Wirtschaftsinformatike, Websites, Online-Medien, Journalisten, Bloggers, Analysten und Investoren weltweit.